Title : Targeting histone deacetyalses in the treatment of B- and T-cell malignancies.

Pub. Date : 2010 Dec

PMID : 21132350






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Presently, two of these agents, vorinostat and romidepsin, have been approved in the US for the treatment of relapsed and refractory cutaneous T cell lymphomas (CTCL). Vorinostat TSPY like 2 Homo sapiens